This file photo shows the exterior of the headquarters of Swiss biotechnology group Actelion in Allschwil, near Basel. U.S. pharmaceuticals giant Johnson & Johnson on Jan. 26 announced it was buying Swiss medical firm Actelion for $30-billion.
Category: Johnson and Johnson
Health Care Companies Showing Good Defensive Potential
Among U.S. companies, health care companies offer good defensive-investing opportunities. Such companies, including Johnson & Johnson , Biogen Inc. and VCA Inc. , generally had strong financial strength and gross margins.